"New Research Calls Affecting Investors on Wall Street"

Today's Important Research Calls

The most talked-about and market-impacting research calls on Wall Street are now in one place. We have compiled important calls that investors should pay attention to in order to make informed decisions.

Jefferies upgraded its rating for DoorDash (DASH) from Hold to Buy and raised the price target to $260. The firm believes it is necessary to take a more positive stance for DoorDash's most profitable business segment after observing rapid growth in U.S. restaurant deliveries over the past four quarters.

Nomura upgraded its rating for Baidu (BIDU) from Neutral to Buy and increased the price target to $140 from the previous $135. The firm noted the "significant growth potential" of Baidu's chip design subsidiary Kunlunxin, in which it holds a 69% stake, and mentioned that management is considering enhancing capital returns.

UBS upgraded Insulet (PODD) from Neutral to Buy and raised the price target to $400 from the previous $355. The firm believes the company can maintain its growth momentum by the end of the decade.

Jefferies upgraded Zions Bancorp (ZION) from Hold to Buy and increased the price target to $60 from the previous $55. It pointed out that concerns regarding fraud allegations in the third quarter and "mini loan fears" have been overstated.

Goldman Sachs upgraded Medtronic (MDT) from Sell to Neutral and raised the price target to $111 from the previous $81. After the second-quarter results, the firm noted that the company has seen an increase in new product momentum and that overall P&L metrics have taken a step in the right direction.

Wells Fargo downgraded Molson Coors (TAP) from Overweight to Equal Weight and reduced the price target to $50 from the previous $53. The company reported that Molson is facing category weakness along with share loss and "tight" costs.

Mizuho downgraded Canadian Solar (CSIQ) from Outperform to Underperform and raised the price target to $21 from the previous $15. It noted that the impact of developments related to the U.S. factory remains uncertain.

BofA downgraded BellRing Brands (BRBR) from Buy to Neutral and reduced the price target to $28 from the previous $50. The decision was made due to the "weak" fourth-quarter results, disputes in the FY26 outlook, and cuts made in the company's long-term sales algorithm.

HSBC downgraded QuantumScape (QS) from Hold to Reduce and raised the price target to $10.50 from the previous $5.30. Although the company made some significant deals, it warned investors about the lack of transparency regarding contract economics.

Truist downgraded GitLab (GTLB) from Buy to Hold and lowered the price target to $44 from the previous $55. It stated that the company may face visibility issues and high execution risk due to its business model transition.

Wells Fargo initiated coverage on AB InBev (BUD) with an Overweight rating and a price target of $75. It indicated a promising structure leading up to the 2026 World Cup along with AB InBev's "cheap" valuation and tactical positioning.

Citizens JMP initiated coverage on Riot Platforms (RIOT) with an Outperform rating and a price target of $25. The company aims to provide critically scarce energy supply for high-performance computing and artificial intelligence, launching coverage on five bitcoin mining companies.

BofA initiated coverage on Extreme Networks (EXTR) with a Buy rating and a price target of $24. It emphasized that the cloud-based campus network solutions provider has a WiFi-7 upgrade cycle that could double its growth forecasts.

Canaccord initiated coverage on Insight Enterprises (NSIT) with a Hold rating and a price target of $100. It expressed that the company has transitioned well from a processor IT reseller to a solution-focused technology partner.

UBS initiated coverage on Parsons (PSN) with a Buy rating and a price target of $107. It highlighted that growth will accelerate supported by a technology-focused M&A strategy with strong order backing, widening margins between the two segments.